These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 12366148)

  • 21. [Recent studies on anti-angiogenesis in cancer therapy].
    Kishi K; Milas L; Hunter N; Sato M
    Nihon Rinsho; 2000 Aug; 58(8):1747-62. PubMed ID: 10944947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice?
    Mancuso A; Sternberg CN
    Crit Rev Oncol Hematol; 2005 Jul; 55(1):67-81. PubMed ID: 15890525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herbal compound triptolide synergistically enhanced antitumor activity of vasostatin120-180.
    Lin Y; Yang X; Lu M; Zheng W; Zhang J; Zhuang H; Hua ZC
    Anticancer Drugs; 2013 Oct; 24(9):945-57. PubMed ID: 23958791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of vascular-targeting drugs in a computational model of tumor growth.
    Gevertz J
    Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Apr; 85(4 Pt 1):041914. PubMed ID: 22680505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Why do tumors become resistant to antiangiogenesis drugs?
    Schmidt C
    J Natl Cancer Inst; 2009 Nov; 101(22):1530-2. PubMed ID: 19880813
    [No Abstract]   [Full Text] [Related]  

  • 27. Tumor angiogenesis--new drugs on the block.
    Brower V
    Nat Biotechnol; 1999 Oct; 17(10):963-8. PubMed ID: 10504695
    [No Abstract]   [Full Text] [Related]  

  • 28. Low-molecular-weight heparins and angiogenesis.
    Norrby K
    APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A therapy inactivating the tumor angiogenic factors.
    Morales-Rodrigo C
    Math Biosci Eng; 2013 Feb; 10(1):185-98. PubMed ID: 23311368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
    Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
    Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The optimal scheduling of two drugs with simple resistance for a problem in cancer chemotherapy.
    Murray JM
    IMA J Math Appl Med Biol; 1997 Dec; 14(4):283-303. PubMed ID: 9415996
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular-target drug].
    Sone S; Yano S; Nishioka Y
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1034-40. PubMed ID: 15272581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiogenesis: an organizing principle for drug discovery?
    Folkman J
    Nat Rev Drug Discov; 2007 Apr; 6(4):273-86. PubMed ID: 17396134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2-selective nonsteroidal anti-inflammatory drugs inhibit hepatocyte growth factor/scatter factor-induced angiogenesis.
    Sengupta S; Sellers LA; Cindrova T; Skepper J; Gherardi E; Sasisekharan R; Fan TP
    Cancer Res; 2003 Dec; 63(23):8351-9. PubMed ID: 14678996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101.
    Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I
    Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiogenesis inhibitors and hypoxia.
    Kieran MW; Folkman J; Heymach J
    Nat Med; 2003 Sep; 9(9):1104; author reply 1104-5. PubMed ID: 12949515
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
    Shojaei F; Ferrara N
    Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synopsis of angiogenesis inhibitors in oncology.
    Ellis LM; Liu W; Fan F; Jung YD; Reinmuth N; Stoeltzing O; Takeda A; Akagi M; Parikh AA; Ahmad S
    Oncology (Williston Park); 2002 May; 16(5 Suppl 4):14-22. PubMed ID: 12102576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular markers of lymphatic and blood vessels, tumorigenesis and targets for blocking metastatic spreading].
    Konenkov VI; Borodin IuI; Bgatova NP
    Vopr Onkol; 2011; 57(3):295-301. PubMed ID: 21882598
    [No Abstract]   [Full Text] [Related]  

  • 40. Is copper chelation an effective anti-angiogenic strategy for cancer treatment?
    Antoniades V; Sioga A; Dietrich EM; Meditskou S; Ekonomou L; Antoniades K
    Med Hypotheses; 2013 Dec; 81(6):1159-63. PubMed ID: 24210000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.